BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2008
View Archived Issues
Phase II results with CPX-1 liposome injection reported
Read More
Improved insulin sensitivity and cholesterol-lowering activity of INCB-13739 in type 2 diabetes
Read More
SGLT2-specific antisense oligonucleotide shows antidiabetic activity in vivo
Read More
Novel glucokinase activator normalizes blood glucose in mild and severe diabetes models
Read More
Axelar receives financing for a phase I/II clinical trial for AXL-1717 in cancer
Read More
Rigel commences two phase IIb trials of R-788 in rheumatoid arthritis
Read More
Good tolerability and preliminary efficacy of baminercept in rheumatoid arthritis
Read More
Molecular Insight initiates phase I Trofex trial in metastatic prostate cancer
Read More
BioLineRx begins phase IIb BL-1020 trial in schizophrenia
Read More
GlaxoSmithKline receives E.U. marketing authorization for Tyverb
Read More
Novartis starts clinical trials for influenza vaccine adjuvanted with Intercell's IC31
Read More
Novartis launches oral iron-chelating agent Exjade for chronic iron overload in Japan
Read More
Positive phase I/II IDX-899 data confirm potent antiviral activity in HIV
Read More
Recent patents report novel analgesic agents
Read More
Calando and City of Hope to initiate phase II clinical trial of IT-101 in lymphoma
Read More
Novel treatments for disorders of impaired metabolism described in recent patent literature
Read More
ChemoCentryx completes enrollment in phase II/III PROTECT-1 clinical trial of Traficet-EN
Read More
Repligen to initiate phase IIb clinical trial of RG-2417 in bipolar disorder
Read More
Cytomedix to enter antiinflammatory peptide CT-112 into clinical development
Read More
Agents for Alzheimer's disease and other neurological disorders disclosed in recent patents
Read More
Axxonis submits MAA to EMEA for Nenad transdermal patch and subcutaneous infusion
Read More
Results from three phase I clinical trials of Cytokinetics' CK-1827452 reported
Read More
Ranbaxy to become subsidiary of Daiichi Sankyo
Read More
FDA approves Requip XL for Parkinson's disease
Read More
Chemokine reports final results of CTCE-9908 phase I/II trial in cancer
Read More